This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Gambro Lundia Ab. Active years: 2018-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2019
Title: Francesco Rosati: Innovator in Extracorporeal Blood Treatment
Introduction
Francesco Rosati is a notable inventor based in Fano, Italy. He has made significant contributions to the field of medical technology, particularly in the area of extracorporeal blood treatment. With a total of 2 patents to his name, Rosati's work is recognized for its innovative approach to improving treatment effectiveness.
Latest Patents
Francesco Rosati's latest patents include an apparatus for determining a parameter indicative of the progress of an extracorporeal blood treatment. This apparatus comprises a treatment unit, a blood withdrawal line, a blood return line, a preparation line, and a spent dialysate line. A control unit is configured to calculate values of a parameter relating to treatment effectiveness based on measures of the conductivity in the spent dialysate line. The effectiveness parameter is calculated using one or more values representative of the conductivity in the spent dialysate line, relying on a mathematical model.
Career Highlights
Rosati is currently employed at Gambro Lundia AB, where he continues to develop innovative solutions in the medical field. His work focuses on enhancing the efficiency and effectiveness of blood treatment processes, contributing to better patient outcomes.
Collaborations
Some of his notable coworkers include Francesco Fontanazzi and Alessandro Surace. Their collaborative efforts in research and development have further advanced the technologies in which they specialize.
Conclusion
Francesco Rosati's contributions to the field of extracorporeal blood treatment exemplify the impact of innovation in medical technology. His patents reflect a commitment to improving treatment methods and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
